300898.SZ
熊猫乳品
SZSE · Consumer Defensive · C 制造业 · CN
CNY 20.42
−1.40%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 845.5M | 811.1M | 764.3M | 946.9M | 891.6M |
| Cost of Revenue | 627.4M | 603.6M | 547.3M | 727.9M | 719.8M |
| Gross Profit | 218.1M | 207.4M | 217.0M | 219.0M | 171.8M |
| Operating Expenses | |||||
| R&D Expense | 14.7M | 15.1M | 19.6M | 17.3M | 18.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 58.1M | 53.6M | 44.2M | 45.0M | 37.7M |
| Selling & Marketing Expense | 43.9M | 40.3M | 37.1M | 41.7M | 54.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 122.8M | 115.0M | 105.2M | 109.6M | 115.2M |
| Cost and Expenses | 750.2M | 718.7M | 652.5M | 837.5M | 835.0M |
| Operating Income (EBIT) | 124.3M | 121.6M | 122.5M | 123.3M | 61.5M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 124.1M | 121.5M | 120.7M | 123.1M | 61.3M |
| Income Tax Expense | 17.4M | 18.0M | 18.9M | 17.4M | 6.2M |
| Bottom Line | |||||
| Net Income | 111.3M | 108.0M | 102.5M | 109.0M | 53.4M |
| Earnings from Cont. Ops | 106.8M | 103.4M | 101.8M | 105.7M | 55.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 111.3M | 108.0M | 102.5M | 109.0M | 53.4M |
| Per Share | |||||
| Basic EPS | CN¥0.90 | CN¥0.87 | CN¥0.83 | CN¥0.88 | CN¥0.43 |
| Diluted EPS | CN¥0.90 | CN¥0.87 | CN¥0.83 | CN¥0.88 | CN¥0.43 |
| Revenue Per Share | CN¥6.82 | CN¥6.54 | CN¥6.16 | CN¥7.61 | CN¥7.18 |
| Shares | |||||
| Basic Shares Outstanding | 124.0M | 124.0M | 124.0M | 124.4M | 124.2M |
| Diluted Shares Outstanding | 124.0M | 124.0M | 124.0M | 124.4M | 124.2M |
| Profitability Metrics | |||||
| EBITDA | — | 149.0M | 147.4M | 146.2M | 82.8M |
| D&A | — | 27.4M | 25.0M | 22.9M | 21.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026